Combinatorial chemistry in cancer drug development

Cancer Journal

Volumn 7, Issue 1, 2001, Pages 79-83

  Leonard, K A ^a   Deisseroth, A B ^a   Austin, D J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Cancer therapy; Chemical diversity; Chemical synthesis; Drug development

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PACLITAXEL; PHOSPHATASE; PROTEIN TYROSINE KINASE;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL SURFACE; CHEMICAL ANALYSIS; DRUG STRUCTURE; MEMBRANE BINDING; METASTASIS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BIOLOGICAL FACTORS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HUMANS; MEMBRANE PROTEINS; PACLITAXEL; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0035092469     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Cell cycle molecular targets in novel anticancer drug discover
2. Discovering novel chemotherapeutic drugs for the third millennium
3. 1001 protein kinases redux towards 2000
4. A gene map of the human genome
5. Harnessing the power of the genome in the search for new antibiotics
6. Proteomics: Translating genomics into products?
7. International collaboration in drug discovery and development: The NCI experience
8. Drug discovery: A historical perspective
9. Combinatorial chemistry and new drugs
10. Historical overview of the developing field of molecular diversity
11. Applications of combinatorial chemistry to drug design and development
12. Target-oriented and diversity-oriented organic synthesis in drug discovery
13. Molecular diversity, biological activity and common ground shared by both
14. Combinatorial chemistry as a tool for drug discovery
15. Can the time from synthesis design to validated chemistry be shortened?
16. Structure-based drug design: Combinatorial chemistry and molecular modeling
17. Natural products in drug discovery and development
18. The search for orally active medications through combinatorial chemistry
19. Glossary of terms used in combinatorial chemistry
20. Application of combinatorial library methods in cancer research and drug discovery
21. Use of large combinatorial chemicals libraries for anticancer drug discovery
22. Tyrosine kinase inhibitors in chronic myeloid leukemia
23. Structures of the tyrosine kinase domain of fibroblast growth factor in complex with inhibitors
24. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
25. Intracellular targets of cylin-dependent kinase inhibitors: Identification by affinity chromatography using immobilized inhibitors
26. Benzodiazepine compounds as inhibitors of the Src protein tyrosine kinase: Screening of a combinatorial library of 1.4-benzodiazepines
27. Design of novel peptidomimetic ligands targeting the pp60srcSH2 domain: Transposed sidechain and rigid scaffold modifications
28. Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain
29. Exploring the specificity pockets of two homologous SH3 domains using structure-based, split-pool synthesis and affinity-based selection
30. Exploring the leucine-proline binding pocket of the Src SH3 domain using structure-based, split-pool synthesis and affinity-based selection
31. Mapping the subsite preferences of protein tyrosine phosphatase PTP-IB using combinatorial chemistry approaches
32. Combinatorial synthesis and biological evaluation of library of small-molecule Ser/Thr-protein phosphatase inhibitors
33. Synthesis and biological evaluation of a targeted library of protein phosphatase inhibitors
34. Design, synthesis and characterisation of affinity ligands for glycoproteins
35. Combinatorial chemistry techniques applied to nonpeptide integrin antagonists
36. Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library
37. P2 purine and pynmidine receptors: Emerging superfamilies of G-protein-coupled and ligand-gated ion channel receptors
38. Discovery and characterization of OC144-093, a novel inhibitors of P-glycoprotein-mediated multidrug resistance
39. Parallel synthesis of tamoxifen and derivatives on solid support via resin capture
40. Designed epothilones: Combinatorial synthesis, tubulin assembly properties, and cytotoxic action against taxol-resistant tumor cells
41. Chemistry, biology and medicine of selected tubulin polymerizing agents
42. Solid and solution phase synthesis and biological evaluation of combinatorial sacrodictyin libraries
43. Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library
44. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors alpha and beta
45. Novel structured templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens
46. Redox active disulfides: The thioredoxin system as a drug target
47. Benzodiazepine peptidomimetic inhibitors of farnesyltransferase
48. De novo design and synthesis of somatostatin non-peptide peptidomimetics utilizing beta-D-glucose as a novel scaffolding
49. A trifunctional steroid-based scaffold for combinatorial chemistry
50. The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library
51. A new efficient method for the synthesis of 1,4-benzodiazepine-2,5-dione diversomers
52. Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part one: Construction of a sub-library of halogenated 5-alkoxy-2(5H)furanones
53. A metathetical cycloaddition-cycloreversion approach to the formation of furan scaffold libraries
54. Are porphyrin mixtures favorable photodynamic anticancer drugs? A model study with combinatorial libraries of tetraphenylporphyrins